Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Neurology
Breast Cancer
Questions discussed in this category
How do you manage neuropathic chemotherapy agents in patients with underlying multiple sclerosis?
Are there contraindications to drugs like oxaliplatin or abraxane? Does chronicity or severity of the patient's underlying symptoms play a role in yo...
1 Answer available
How do you modify TNBC neoadjuvant chemotherapy in patients with multiple sclerosis?
1 Answer available
How would you manage adjuvant endocrine therapy for a postmenopausal patient with early stage HR+ breast CA who develops an ischemic CVA on an AI?
Presuming that work-up for cardioembolic sources is negative, how would you proceed?
1 Answer available
12137
10144
9444
Papers discussed in this category
Circulation, 2020 Feb 17
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
N. Engl. J. Med.,
Pembrolizumab for Early Triple-Negative Breast Cancer.
Related Topics in Neurology
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Non-malignant Disease
Pediatric Oncology
Thoracic Malignancies